Capsugel Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Capsugel Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3391
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the bioavailability, targeted delivery and overall performance of their products. Capsugel partners with numerous customers in several countries to create novel, high-quality and customized solutions that align with its customers’ evolving needs and benefit consumers and patients. The company has 13 manufacturing sites and three research and development centers in nine countries across three continents. Capsugel is headquartered in Morristown, New Jersey, the US.

Capsugel Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Capsugel Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Capsugel Inc, Medical Devices Deals, 2012 to YTD 2018 9
Capsugel Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Capsugel Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Capsugel Acquires Ionic Liquids Technology from Monash University 11
Partnerships 12
Capsugel Enters into Agreement with Pulmatrix 12
Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 13
Quotient Clinical Enters Into Co-Development Agreement With Capsugel 14
Catalent Pharma Solutions Enters Into Agreement With Bend Research 15
Licensing Agreements 16
Bend Research Enters Into Licensing Agreement With Affinium For SDD Technology 16
Bend Research Enters Into Licensing Agreement With Eli Lilly For SDD Technology 17
Acquisition 18
Lonza Acquires Capsugel from KKR & Co for USD5.5 Billion 18
Capsugel Acquires Xcelience 20
Capsugel Completes Acquisition Of Bend Research, Drug Delivery Technologies Company 21
Capsugel Belgium Acquires Encap Drug Delivery 22
Capsugel Inc – Key Competitors 23
Capsugel Inc – Key Employees 24
Capsugel Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 28
Other Significant Developments 28
Feb 11, 2017: Capsugel Expands Operations and Capabilities at Scotland Unit 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Capsugel Inc, Pharmaceuticals & Healthcare, Key Facts 2
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Capsugel Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Capsugel Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Capsugel Inc, Medical Devices Deals, 2012 to YTD 2018 9
Capsugel Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Capsugel Acquires Ionic Liquids Technology from Monash University 11
Capsugel Enters into Agreement with Pulmatrix 12
Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 13
Quotient Clinical Enters Into Co-Development Agreement With Capsugel 14
Catalent Pharma Solutions Enters Into Agreement With Bend Research 15
Bend Research Enters Into Licensing Agreement With Affinium For SDD Technology 16
Bend Research Enters Into Licensing Agreement With Eli Lilly For SDD Technology 17
Lonza Acquires Capsugel from KKR & Co for USD5.5 Billion 18
Capsugel Acquires Xcelience 20
Capsugel Completes Acquisition Of Bend Research, Drug Delivery Technologies Company 21
Capsugel Belgium Acquires Encap Drug Delivery 22
Capsugel Inc, Key Competitors 23
Capsugel Inc, Key Employees 24
Capsugel Inc, Other Locations 25
Capsugel Inc, Subsidiaries 26

List of Figures
Capsugel Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Capsugel Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Capsugel Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Capsugel Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jamaica Public Service Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Jamaica Public Service Co Ltd (JPS) is an integrated electric utility which generates, procures, transmits, distributes and supplies power. It produces electricity from heavy fuel oil, automotive diesel oil, and hydro sources; and procures energy from independent power producers. The company …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Exfo Inc.:企業の戦略・SWOT・財務分析
    Exfo Inc. - Strategy, SWOT and Corporate Finance Report Summary Exfo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Dynemic Products Ltd.:企業の戦略・SWOT・財務情報
    Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • STR Holdings Inc:企業の戦略的SWOT分析
    STR Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Indiana Municipal Power Agency-エネルギー分野:企業M&A・提携分析
    Summary Indiana Municipal Power Agency (IMPA) is a not-for-profit wholesale power provider supplying power to cities and communities across Indiana and Ohio. The agency was formed by its member utilities which enable them to share power resources and provide electricity economically to their custome …
  • Bird Construction Inc (BDT):企業の財務・戦略的SWOT分析
    Bird Construction Inc (BDT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cabela’s Incorporated:企業の戦略・SWOT・財務情報
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Engro Corp Ltd (ENGRO):企業の財務・戦略的SWOT分析
    Engro Corp Ltd (ENGRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • SgurrEnergy Ltd:企業の戦略的SWOT分析
    SgurrEnergy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sermonix Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company provides lead product such as lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting wom …
  • TOTAL S.A.:企業の戦略・SWOT・財務情報
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Voith GmbH & Co KGaA:企業の戦略的SWOT分析
    Voith GmbH & Co KGaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • UNIQA Biztosito Zrt.:企業の戦略・SWOT・財務情報
    UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report Summary UNIQA Biztosito Zrt. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Keane Group Inc (FRAC):企業の財務・戦略的SWOT分析
    Keane Group Inc (FRAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • A123 Systems LLC:企業の戦略的SWOT分析
    A123 Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆